Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
John Abbott Maintained (ARCT) at Buy with Increased Target to $58 on, Mar 8th, 2024
John Abbott of Wells Fargo, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Buy with Increased Target from $45 to $58 on, Mar 8th, 2024.
John has made no other calls on ARCT in the last 4 months.
There are 2 other peers that have a rating on ARCT. Out of the 2 peers that are also analyzing ARCT, 0 agree with John's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with John
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $48 on, Thursday, February 8th, 2024
- Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy on, Wednesday, December 13th, 2023
